These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9949508)
21. Shigellosis in children: a clinico-epidemiological comparison between Shigella dysenteriae type I and Shigella flexneri. Faruque AS; Teka T; Fuchs GJ Ann Trop Paediatr; 1998 Sep; 18(3):197-201. PubMed ID: 9924557 [TBL] [Abstract][Full Text] [Related]
22. Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice. Farzam N; Ramon-Saraf R; Banet-Levi Y; Lerner-Geva L; Ashkenazi S; Kubler-Kielb J; Vinogradov E; Robbins JB; Schneerson R Vaccine; 2017 Sep; 35(37):4990-4996. PubMed ID: 28797729 [TBL] [Abstract][Full Text] [Related]
23. Azithromycin-Nonsusceptible Shigella flexneri 3a in Men Who Have Sex with Men, Taiwan, 2015-2016. Liao YS; Liu YY; Lo YC; Chiou CS Emerg Infect Dis; 2016 Feb; 23(2):345-346. PubMed ID: 28098533 [TBL] [Abstract][Full Text] [Related]
24. Genome sequence of Shigella flexneri strain SP1, a diarrheal isolate that encodes an extended-spectrum β-lactamase (ESBL). Shen P; Fan J; Guo L; Li J; Li A; Zhang J; Ying C; Ji J; Xu H; Zheng B; Xiao Y Ann Clin Microbiol Antimicrob; 2017 May; 16(1):37. PubMed ID: 28499446 [TBL] [Abstract][Full Text] [Related]
26. Shigella and shigellaemia. De Mol P; Brasseur D; Schatteman E; Kassam S Scand J Infect Dis; 1981; 13(1):75-7. PubMed ID: 7017908 [TBL] [Abstract][Full Text] [Related]
27. Shigella flexneri: from in vitro invasion of epithelial cells to infection of the intestinal barrier. Sansonetti PJ Biochem Soc Trans; 1994 May; 22(2):295-8. PubMed ID: 7958310 [No Abstract] [Full Text] [Related]
28. [The microbiological aspects of using enterosorbents in acute intestinal infections]. Nikolaeva LG Lik Sprava; 1993 Jul; (8):81-3. PubMed ID: 8079486 [TBL] [Abstract][Full Text] [Related]
29. Clinical implications of reduced susceptibility to fluoroquinolones in paediatric Shigella sonnei and Shigella flexneri infections. Thompson CN; Thieu NT; Vinh PV; Duc AN; Wolbers M; Vinh H; Campbell JI; Ngoc DT; Hoang NV; Thanh TH; The HC; Nguyen TN; Lan NP; Parry CM; Chau NV; Thwaites G; Thanh DP; Baker S J Antimicrob Chemother; 2016 Mar; 71(3):807-15. PubMed ID: 26679253 [TBL] [Abstract][Full Text] [Related]
34. [Disruption of microbiocenosis of the large intestine and the immune and interferon status in children with bacterial complications of acute viral infections of the respiratory tract and their correction by high doses of bifidumbacterin forte]. Lykova EA; Vorob'ev AA; Bokovoĭ AG; Pobedinskaia IN; Gevondian VS; Gevondian NM; Mitrokhin SD; Minaev VI; Dzis NB; Makkaveeva LF; Kovalev IV; Murashova AO; Bondarenko VM Antibiot Khimioter; 2000; 45(10):22-7. PubMed ID: 11212396 [TBL] [Abstract][Full Text] [Related]
35. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection. Phalipon A; Tanguy M; Grandjean C; Guerreiro C; Bélot F; Cohen D; Sansonetti PJ; Mulard LA J Immunol; 2009 Feb; 182(4):2241-7. PubMed ID: 19201878 [TBL] [Abstract][Full Text] [Related]
36. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Kotloff KL; Winickoff JP; Ivanoff B; Clemens JD; Swerdlow DL; Sansonetti PJ; Adak GK; Levine MM Bull World Health Organ; 1999; 77(8):651-66. PubMed ID: 10516787 [TBL] [Abstract][Full Text] [Related]
37. [Interrelation of virulent and avirulent (vaccinal) strains of Shigella flexneri 2A in long-term bacterial carriage in gnotobiotic rats]. Belaia IuA; Chakhava OV; Bystrova SM; Shustrova NM; Popova LIu Zh Mikrobiol Epidemiol Immunobiol; 1984 Mar; (3):82-9. PubMed ID: 6375221 [TBL] [Abstract][Full Text] [Related]
38. Serum antibody responses against shigella lipopolysaccharides and invasion plasmid-coded antigens in shigella infected Swedish patients. Li A; Rong ZC; Ekwall E; Forsum U; Lindberg AA Scand J Infect Dis; 1993; 25(5):569-77. PubMed ID: 8284641 [TBL] [Abstract][Full Text] [Related]
39. Cephalosporin resistant Shigella flexneri from a clinical isolate--a rare finding. Sabir N; Zafar A J Pak Med Assoc; 2005 Dec; 55(12):560-1. PubMed ID: 16438280 [TBL] [Abstract][Full Text] [Related]
40. Cefotaximase and AmpC-producing Shigella flexneri in case of dysentery from southern India. Oommen S; Pillai PM; Sushamabai S; Paul PJ Indian J Med Microbiol; 2013; 31(1):77-9. PubMed ID: 23508436 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]